Revvity Total Long-Term Assets 2010-2024 | RVTY

Revvity total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Revvity total long-term assets for the quarter ending September 30, 2024 were $10.321B, a 1.78% decline year-over-year.
  • Revvity total long-term assets for 2023 were $10.564B, a 2.56% decline from 2022.
  • Revvity total long-term assets for 2022 were $10.841B, a 13.68% decline from 2021.
  • Revvity total long-term assets for 2021 were $12.56B, a 119.52% increase from 2020.
Revvity Annual Total Long-Term Assets
(Millions of US $)
2023 $10,564
2022 $10,841
2021 $12,560
2020 $5,721
2019 $5,164
2018 $4,741
2017 $4,892
2016 $3,087
2015 $3,133
2014 $3,059
2013 $2,902
2012 $2,930
2011 $2,973
2010 $2,124
2009 $2,175
Revvity Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $10,321
2024-06-30 $10,266
2024-03-31 $10,373
2023-12-31 $10,564
2023-09-30 $10,508
2023-06-30 $10,695
2023-03-31 $10,843
2022-12-31 $10,841
2022-09-30 $10,707
2022-06-30 $12,082
2022-03-31 $12,394
2021-12-31 $12,560
2021-09-30 $12,649
2021-06-30 $6,479
2021-03-31 $6,088
2020-12-31 $5,721
2020-09-30 $5,190
2020-06-30 $5,105
2020-03-31 $5,043
2019-12-31 $5,164
2019-09-30 $4,941
2019-06-30 $5,061
2019-03-31 $4,839
2018-12-31 $4,741
2018-09-30 $4,697
2018-06-30 $4,755
2018-03-31 $4,892
2017-12-31 $4,892
2017-09-30 $3,193
2017-06-30 $3,171
2017-03-31 $3,224
2016-12-31 $3,087
2016-09-30 $3,151
2016-06-30 $3,115
2016-03-31 $3,161
2015-12-31 $3,133
2015-09-30 $2,958
2015-06-30 $3,012
2015-03-31 $3,006
2014-12-31 $3,059
2014-09-30 $2,812
2014-06-30 $2,856
2014-03-31 $2,873
2013-12-31 $2,902
2013-09-30 $2,903
2013-06-30 $2,905
2013-03-31 $2,911
2012-12-31 $2,930
2012-09-30 $2,949
2012-06-30 $2,903
2012-03-31 $2,956
2011-12-31 $2,973
2011-09-30 $2,472
2011-06-30 $2,520
2011-03-31 $2,218
2010-12-31 $2,124
2010-09-30 $2,270
2010-06-30 $2,222
2010-03-31 $2,136
2009-12-31 $2,175
2009-09-30 $2,208
2009-06-30 $2,126
2009-03-31 $2,078
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00